Steroid and Cytokine Regulation of MMP Expression in Endometriosis – (10-10-02)



Steroid and Cytokine Regulation of MMP Expression in Endometriosis

Cutting through the technical jargon, this article brings to light a potentially important factor for treatment of endometriosis. Progesterone is key here. Progesterone inhibits the ability of an enzyme, MMP, to establish endometriosis. This ability of progesterone can itself be inhibited by certain mechanisms. This study finds that the use of retinoic acid (vitamin A related compounds) and transforming growth factor beta (a cytokine controlling cell maturation) can restore progesterone’s protective ability. As added info, many women today, as a result of exposure to way too many exogenous estrogens, go through anovulatory cycles. Without the release of an ovum during a normal menstrual cycle, the body lacks that normal exposure to progesterone that is so needed for normal female reproductive function.

JCEM — Abstracts: Bruner-Tran et al. 87 (10): 4782

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Endometriosis
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”